The pecking order in the U.S. echocardiography market remains unchanged, but Siemens and GE are gaining ground, according to a report by Klein Biomedical. Market leader Philips Medical Systems lost share last year to both Siemens and GE Medical. Siemens
The pecking order in the U.S. echocardiography market remains unchanged, but Siemens and GE are gaining ground, according to a report by Klein Biomedical. Market leader Philips Medical Systems lost share last year to both Siemens and GE Medical. Siemens is closing in from its number two position; GE is ranked third. Siemens' gains are coming from the growing popularity of its Acuson Sequoia. Unit shipments of the company's flagship product increased more than 21%, according to Siemens, making Sequoia the best-selling ultrasound system in the U.S. for the sixth year in a row. The Klein report estimates that the U.S. market for ultrasound was essentially flat in 2002, with total revenues of $1.14 billion, managing a mere 0.3% percent increase over 2001.
Study: AI Boosts Ultrasound AUC for Predicting Thyroid Malignancy Risk by 34 Percent Over TI-RADS
February 17th 2025In a study involving assessment of over 1,000 thyroid nodules, researchers found the machine learning model led to substantial increases in sensitivity and specificity for estimating the risk of thyroid malignancy over traditional TI-RADS and guidelines from the American Thyroid Association.
Can CT-Based AI Provide Automated Detection of Colorectal Cancer?
February 14th 2025For the assessment of contrast-enhanced abdominopelvic CT exams, an artificial intelligence model demonstrated equivalent or better sensitivity than radiologist readers, and greater than 90 percent specificity for the diagnosis of colorectal cancer.
Emerging PET/CT Agent Shows Promise in Detecting PCa Recurrence in Patients with Low PSA Levels
February 13th 202518F-DCFPyL facilitated detection of recurrent prostate cancer in 51 percent of patients with PSA levels ranging between 0.2 to 0.5 ng/ml, according to new research presented at the American Society of Clinical Oncology Genitourinary Cancers (ASCO-GU) Symposium.